Circulating osteogenic precursor cells in heterotopic bone formation. - Wikidata - wikimedia - TriplyDB

Circulating osteogenic precursor cells in heterotopic bone formation.

Circulating osteogenic precursor cells in heterotopic bone formation.

http://www.wikidata.org/entity/Q36393631

about

Overactive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophy Heterotopic mineralization (ossification or calcification) in tendinopathy or following surgical tendon trauma Characterization of Cells Isolated from Genetic and Trauma-Induced Heterotopic Ossification Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis From mysteries to medicines: drug development for fibrodysplasia ossificans progressive Circulating osteogenic cells: characterization and relationship to rates of bone loss in postmenopausal women.The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling.Fibrodysplasia ossificans progressiva: a blueprint for metamorphosis.Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture.Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells.Synergistic inhibition of endochondral bone formation by silencing Hif1α and Runx2 in trauma-induced heterotopic ossification.Role for circulating osteogenic precursor cells in aortic valvular disease.Pathogenesis and prevention strategies of heterotopic ossification in total hip arthroplasty: a narrative literature review and results of a survey in Germany.Osteoblasts Have a Neural Origin in Heterotopic Ossification.Botulinum Toxin-induced Muscle Paralysis Inhibits Heterotopic Bone Formation A novel population of cells expressing both hematopoietic and mesenchymal markers is present in the normal adult bone marrow and is augmented in a murine model of marrow fibrosis.The role of endothelial-mesenchymal transition in heterotopic ossification.Osteogenic potential of alpha smooth muscle actin expressing muscle resident progenitor cells.MiR-630 Inhibits Endothelial-Mesenchymal Transition by Targeting Slug in Traumatic Heterotopic Ossification.Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche Circulating osteogenic precursor cells The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons Circulating osteogenic cells: implications for injury, repair, and regeneration.Picking a bone with heterotopic ossification: translational progress current and future.Secreted klotho protein attenuates osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro via inactivation of the FGFR1/ERK signaling pathway.Association Between Circulating Osteogenic Progenitor Cells and Disability and Frailty in Older Persons: The Nepean Osteoporosis and Frailty Study.Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification.Effect of G-CSF on the osteoinductive property of a BCP/blood clot composite.Glast-expressing progenitor cells contribute to heterotopic ossification.Tendon mineralization is progressive and associated with deterioration of tendon biomechanical properties, and requires BMP-Smad signaling in the mouse Achilles tendon injury model Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva.Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification.Acceleration of bone repair in NOD/SCID mice by human monoosteophils, novel LL-37-activated monocytes.Allele-specific RNA interference in FOP silencing the FOP gene.Inflammation in bone physiology and pathology.Ascorbic Acid Attenuates Senescence of Human Osteoarthritic Osteoblasts.Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications.Animal models of fibrodysplasia ossificans progressiva.Cholecystitis and cholelithiasis associated with an intramural fasciitis-like proliferation and osseous metaplasia.

P2860

Q26864900-896DB8A8-389E-478F-B6EC-FA914D2D5EEE Q26866352-3AAE98D1-1F57-4F71-BA0D-3B0D6DDED818 Q28553406-3314255F-C71E-4135-AC57-151F55AECD71 Q30410917-2F28871D-3E58-4671-B039-D88DC206E22E Q33555767-C0FD5698-0AA7-4D20-8D83-D4E1FD1BC964 Q33937903-A598C1E2-F9C3-4B63-88F5-FF67BCBC724E Q34020080-A267411F-9B81-451E-8923-43205C6C89DC Q34029378-28986994-2534-4FD6-B23E-15C498EDD135 Q34437408-DC370DD7-2E14-4321-8A66-A5D7A79FCA2C Q34606971-68719BCF-6F26-44BC-8C16-4174E5741E62 Q35144383-D7B58512-A266-4752-B326-424B47D2BC79 Q35563353-6085A57C-397E-4092-82A9-8E220F750011 Q35566376-14A66B27-E62F-4238-9DDC-4407145D5802 Q35912390-278C3670-C054-4CFA-A08B-4C4E5EFA8492 Q35912397-D13BE1DE-BAF8-43C8-A5B9-11E511EE9943 Q35951985-467163EE-FE4D-4C50-86CD-20E54B646B3A Q36204094-4FE98841-C9A6-425F-AF2A-B032EA03A50E Q36586438-6D7DCBA3-2D88-4B3B-ABD8-B492EF48E466 Q36651240-77C1D6E0-E62D-4354-BAEE-8D0C3C909C91 Q36915154-EA363BFA-4BD7-4279-B52F-A3B0F185A5D8 Q37122244-71E5F084-76EC-4B00-9FF2-3BB250A17A8A Q37182424-F9ACE0C3-B796-43E6-85B0-E35C6DE7F917 Q37716166-444ED76A-CAB1-4025-9CFC-8EAE89BF7C62 Q37871512-CB892B7B-A199-415D-B51B-BC164DE600D8 Q38964373-8048B823-F59D-4512-8C79-E5E4C65C2F8A Q40274713-B4C1D484-5C84-4F11-BCF6-B92E92C577FD Q40366435-8B4DA7A4-A10E-44B6-B2B6-488EBA4C6B11 Q40459563-A443F60F-EF5F-4DDA-9CF6-4FE2256839ED Q41346921-7538994F-A38D-4C70-AE91-CD7C0250A39C Q41888575-78CC2659-28A4-4BD4-9DE9-83A70953FF59 Q41917329-178E2765-B555-4D2D-9D12-E218D865343D Q42057000-105EA4B7-562B-47EB-958A-C76695E268C3 Q42178355-5F79AE6C-F042-4684-8473-3B0EF42072EF Q43106630-878F8570-2C01-40BE-B934-020D7E53A654 Q45875489-F65ACA1A-A9E1-4F5D-BB00-FAB58D6CEBB9 Q46010612-6CEE64D4-632A-4044-8A98-E7578ACAFCD1 Q46251820-D798009F-2CF2-48E1-A35B-D093E2389B9C Q47991308-6581D1B1-201A-43BD-B5C7-D1BF75583644 Q48302210-9129D507-BA03-470E-BF93-04B615DDC014 Q50151318-7A874606-6AF4-46F0-908A-514A5B4340A5

P2860

Circulating osteogenic precursor cells in heterotopic bone formation.

http://www.wikidata.org/entity/Q36393631

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Circulating osteogenic precursor cells in heterotopic bone formation.

@ast

Circulating osteogenic precursor cells in heterotopic bone formation.

@en

type

label

Circulating osteogenic precursor cells in heterotopic bone formation.

@ast

Circulating osteogenic precursor cells in heterotopic bone formation.

@en

prefLabel

Circulating osteogenic precursor cells in heterotopic bone formation.

@ast

Circulating osteogenic precursor cells in heterotopic bone formation.

@en

P1433

Q36393631-BB198266-C5E6-453A-8024-207E49DF62E0

P1476

Q36393631-F1E89047-1500-4D32-B2AF-2A0EBC016878

P2093

Q36393631-01AE208E-E3BB-4DB0-BACF-318B2389AA57

Q36393631-08176658-0DC0-4AD3-9B10-FA76BDEFEF87

Q36393631-40858977-2E05-4B9E-AC63-49A5184DBBB3

Q36393631-534B245C-5D78-440C-872A-849BB3D0EAD1

Q36393631-5DF23E17-DDB9-4C1C-9FA4-65CB9E1D8CA1

Q36393631-A095BE41-3BEF-4AE6-B68D-2CEE72422544

Q36393631-F7B03193-ABF7-4754-8D3E-B5E52D3A2939

Q36393631-FC50C057-F6FE-4C0A-8618-5249B73FB98E

Q36393631-FE6F20A1-28AC-4A0A-A55A-775B12B71674

P2860

Q36393631-0509093E-25BF-498C-8593-34F097F72BA4

Q36393631-0576149F-017E-49F8-A37B-9E5AD16C369F

Q36393631-118CD520-80C8-4092-ACBA-DD64C85554B2

Q36393631-11939C8A-BF3E-4975-9072-D77BFD60C616

Q36393631-1515C801-5056-49D8-9755-D5DA89F31C79

Q36393631-1689AC92-A91C-4202-ACA1-BBCB70A91ED9

Q36393631-19773AE9-D2D1-4065-98DE-95AD927761AA

Q36393631-1CE6E659-F3C6-4B6C-ABE6-721EE4076C49

Q36393631-24669C5F-670E-4377-990F-15F0B0DC127F

Q36393631-3B5B6A3B-E306-430C-A38C-AE4C69E5575E

P304

Q36393631-00413BDE-9DEC-44BF-B25D-15232A87B57E

P31

Q36393631-070ECFC7-FEB8-4401-8D85-87132B9A9AEF

P356

Q36393631-525D0744-A611-4A55-B8BC-01797548B19F

P433

Q36393631-CF29D468-D0E4-4300-81EF-9F7C9BD97CCD

P478

Q36393631-BDE632C2-CA52-40B4-9D20-8C3FBB4097DF

P577

Q36393631-1C5F3BEA-1F57-4FEE-B3BA-D929F8302892

P5875

Q36393631-B825897C-F49D-41BF-A825-07C6FEC8B17F

P698

Q36393631-F88B8BDD-2412-4A43-8811-2C2E343B8DD7

P932

Q36393631-58860746-8055-4350-955E-C95138A3A5FE

P356

P1433

P1476

Circulating osteogenic precursor cells in heterotopic bone formation.

@en

P2093

David L Glaser

http://www.w3.org/2001/XMLSchema#string

David L Porter

http://www.w3.org/2001/XMLSchema#string

Eileen M Shore

http://www.w3.org/2001/XMLSchema#string

Jung-Hoon Kim

http://www.w3.org/2001/XMLSchema#string

Kevin P Egan

http://www.w3.org/2001/XMLSchema#string

Paul C Billings

http://www.w3.org/2001/XMLSchema#string

Robert J Pignolo

http://www.w3.org/2001/XMLSchema#string

Robin K Suda

http://www.w3.org/2001/XMLSchema#string

Ruth McCarrick-Walmsley

http://www.w3.org/2001/XMLSchema#string

P2860

A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva

BMP type I receptor inhibition reduces heterotopic [corrected] ossification

Mesenchymal precursor cells in the blood of normal individuals

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1

Identification of progenitor cells that contribute to heterotopic skeletogenesis

Progressive osseous heteroplasia.

Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells.

A human peripheral blood monocyte-derived subset acts as pluripotent stem cells

Incidence of heterotopic bone formation after major hip surgery.

P304

2209-2219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/STEM.150

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26287940

http://www.w3.org/2001/XMLSchema#string

P698

19522009

http://www.w3.org/2001/XMLSchema#string

P932

3496263

http://www.w3.org/2001/XMLSchema#string